AVTX - Avalo Therapeutics - Stock Forecast

Coverage Performance Price Targets & Ratings Chart Insider Trading

AVTX is currently covered by 1 analysts with an average price target of $6.03. This is a potential upside of $1.28 (26.95%) from yesterday's end of day stock price of $4.75.

Avalo Therapeutics's activity chart (see below) currently has 0 price targets and 3 ratings on display. The stock rating distribution of AVTX is 100% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 44.44% with an average time for these price targets to be met of 73.33 days.

Highest price target for AVTX is $0.75, Lowest price target is $0.75, average price target is $6.03.

Most recent stock forecast was given by LELAND GERSHELL from OPPENHEIMER on 27-Jun-2023. First documented stock forecast 18-Nov-2020.

Best performing analysts who are covering AVTX - Avalo Therapeutics:

Gregory Renza Chris Howerton Leland Gershell

Currently out of the existing stock ratings of AVTX, 1 are a HOLD (100%).

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

10

9 months 2 days ago

0/2 (0%)

$3.79 (61.03%)

Hold

0.75

$-3.92 (-83.94%)

9

9 months 3 days ago

2/3 (66.67%)

$0.25 (50.00%)

210

Hold

3

$-1.67 (-35.76%)

9

1 years 1 months 21 days ago

2/3 (66.67%)

$-0.2 (-6.25%)

10

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is AVTX (Avalo Therapeutics) average time for price targets to be met?

On average it took 73.33 days on average for the stock forecasts to be realized with a an average price target met ratio 44.44

Which analyst has the current highest performing score on AVTX (Avalo Therapeutics) with a proven track record?

GREGORY RENZA

Which analyst has the current lower performing score on AVTX (Avalo Therapeutics) with a proven track record?

LELAND GERSHELL

Which analyst has the most public recommendations on AVTX (Avalo Therapeutics)?

Gregory Renza works at RBC and has 11 price targets and 7 ratings on AVTX

Which analyst is the currently most bullish on AVTX (Avalo Therapeutics)?

Leland Gershell with highest potential upside - $0

Which analyst is the currently most reserved on AVTX (Avalo Therapeutics)?

Gregory Renza with lowest potential downside - -$3.92

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?